Results 331 to 340 of about 2,947,895 (397)
Some of the next articles are maybe not open access.

Selective Serotonin Reuptake Inhibitors

2018
The first antidepressants were created by chance but brought the idea that central serotonin agonism produced an antidepressant effect. SSRIs were the first class of psychotropic medications to be rationally designed, meaning that researchers intended to utilize a specific mechanism of action while avoiding adverse effects.
Dee, Lochmann, Tara, Richardson
openaire   +2 more sources

Bivalent biogenic amine reuptake inhibitors

Bioorganic & Medicinal Chemistry Letters, 2003
A series of aryltropane-based bivalent ligands was prepared and investigated for binding potency and for their ability to inhibit reuptake of human dopamine, serotonin and norepinephrine transporters. The bivalent ligand 4, comprised of linking an aryltropane by an octamethylene spacer showed high efficacy for the human dopamine transporter and had a ...
Keith, Fandrick   +4 more
openaire   +2 more sources

Duloxetine: A Dual Reuptake Inhibitor

Annals of Pharmacotherapy, 2004
OBJECTIVE To review the pharmacology, pharmacokinetics, clinical efficacy, and safety profile of duloxetine for the treatment of major depressive disorder (MDD). DATA SOURCES Searches using MEDLINE and PsycINFO were conducted (1966 to November 2003). STUDY SELECTION AND DATA EXTRACTION All duloxetine MDD information gathered was considered.
Sara E, Dugan, Matthew A, Fuller
openaire   +2 more sources

Selective Serotonin Reuptake Inhibitors

2016
Selective serotonergic reuptake inhibitors (SSRIs) are a class of medications used frequently to address issues related to stroke and post-stroke recovery. Health care providers who care for stroke patients will need to familiarize themselves with their applications in stroke treatment.
Ali Saad   +2 more
openaire   +2 more sources

Selective serotonin reuptake inhibitors

Nurse Prescribing, 2010
Selective serotonin reuptake inhibitors (SSRIs) are used widely for the treatment of depression and anxiety disorders, and different SSRIs have different licence indications. They prevent the reuptake of serotonin in the synapse between nerve cells; they should be used with caution in children and adolescents owing to the possible side-effect of an ...
openaire   +1 more source

Serotonin and Norepinephrine Reuptake Inhibitors

2018
This chapter covers antidepressants that fall into the class of serotonin (5-HT) and norepinephrine (NE) reuptake inhibitors. That is, they bind to the 5-HT and NE transporters with varying levels of potency and binding affinity ratios. Unlike the selective serotonin (5-HT) reuptake inhibitors (SSRIs), most of these antidepressants have an ascending ...
openaire   +2 more sources

Selective Serotonin Reuptake Inhibitors

2011
Selective serotonin reuptake inhibitors (SSRIs) are one of the newer classes of antidepressants. Since their introduction in the United States, they have been greatly used and accepted in the psychiatric field (1). SSRIs presently available in the United States include fluoxetine, paroxetine, sertraline, fluvoxamine, and citalopram.
openaire   +1 more source

Postpartum Hemorrhage and Use of Serotonin Reuptake Inhibitor Antidepressants in Pregnancy

Obstetrics and Gynecology, 2016
G. Hanley   +4 more
semanticscholar   +1 more source

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom, Yehuda Zadik
exaly  

Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy‐induced neuropathic pain

European Journal of Pain, 2015
G. Hache   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy